Caitong International Asset Management’s MAIA Biotechnology MAIA Stock Holding History

Caitong International Asset Management’s Portfolio MAIA Stock Details MAIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$302	Buy	+210	New	+$279	﹤0.01%	1900

Other funds holding MAIA

CWM

Centric Wealth Management Chicago, Illinois $643M AUM 21% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BFG

Bleakley Financial Group Fairfield, New Jersey $7.85B AUM 31.48% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

PAM

PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return

LCM

Lazari Capital Management Woodland Hills, California $325M AUM 32.83% 1-Year Est. Return

Atria Investments Charlotte, North Carolina $9.98B AUM 26.5% 1-Year Est. Return

CAG

Centerpoint Advisory Group Overland Park, Kansas $158M AUM 26.37% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

DSC

Daytona Street Capital Saint Louis, Missouri $137M AUM

Caitong International Asset Management's MAIA Position: Q2 2026 in Review

Caitong International Asset Management opened a new position in MAIA Biotechnology (MAIA) in Q2 2026: 210 shares worth $302. The stake represents ﹤0.01% of the portfolio and ranks #1900 among its holdings.

12 funds tracked by Wall St. Rank hold MAIA as of Q2 2026.

Caitong International Asset Management held 210 shares of MAIA Biotechnology worth $302 as of Q2 2026.
MAIA Biotechnology was a new Caitong International Asset Management position in Q2 2026.
MAIA Biotechnology made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #1900 holding.
12 funds tracked by Wall St. Rank held MAIA Biotechnology as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.